The potential cost-effectiveness of the Diamondback 360(R) Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approach

Conclusions:
Based on economic modeling, the recently approved coronary OAS device is projected to be highly cost-effective for patients who undergo PCI for severely calcified lesions.

Source: Therapeutic Advances in Cardiovascular Disease - April 6, 2016 Category: Cardiology Authors: Chambers, J., Genereux, P., Lee, A., Lewin, J., Young, C., Crittendon, J., Mann, M., Garrison, L. P. Tags: Original Research Source Type: research